Waiting for our 2nd day of the ESTRO online workshop on #breastcancer with amazing co-teachers Philip Poortmans, Orit Kaidar-Person, Sandra Hol, Senem Alanyali and Andrea Collavini from @ESTRO_RT
Integration of CDK4/6inhibitors with radiation therapy?
In the adjuvant setting should be avoided because of limited data!
In the metastatic setting the available data encouraging the combination might be safe
@OncoAlert#florencebreast23
➡️Combining RT with anti-Her2 agents
⛔️main concerns: ❤️🩹toxicity and pneumonitis (for eBC)
EARLY-SETTING
✅ Lapatinib, Trast, Pert
⚠️no data for Neratinib
MBC
✅ Lapatibib, Trast, Pert even for intracranial RT
@OncoAlert
Check out what’s popular this week in #JCO:
Impact of F-Labeled Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography Versus Conventional Staging in Patients With Locally Advanced #BreastCancer ➡️ https://t.co/Bh5dSu3e80 #BCSM#oncorad
Dose-escalated SIB #radiotherapy in early #breastcancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, randomised controlled trial
Another amazing job led by Charlotte Coles and the UK breast network @ESTRO_RT@OncoAlert#radonc#OncoAlert
https://t.co/W8Tqvb4cx8
New article on coronary calcium score and its impact on survival for lung cancer patients. National collaboration thanks to @DCCC_RT. Tumor and patient-related factors are the most important.
@RadiotherapyOn1 @onko_ouh https://t.co/VYICGyp15V
End of another great @ESTRO_RT #ESTRO school course on ‘IMRT/VMAT and other highly conformal techniques in clinical practice’ in Turin, IT! Thanks delegates and faculty
The NATALEE trial was presented today. A deep critical evaluation of its results is warranted. It would be great if presentations steered clear of hype phrases like "highly significant" or "safe and well tolerable" #ASCO23#bcsm
Excellent article with practical tips by @hoperugo Real-World Perspectives for Pneumonitis/Interstitial Lung Disease Associated With Trastuzumab Deruxtecan Use in Her-2 + #MetastaticBreastCancer https://t.co/oL2jSKYSFr @ASCO@JCOOP_ASCO@OncoAlert
With #ASCO23-week officially here, it is time for a #top10 list of breast abstracts! Several potentially practice-changing trials to be presented during the congress. Take a look, share if you found it useful and feel free to recommend additional impactful abstracts to add! #bcsm
The monarchE trial of adjuvant abemaciclib endocrine therapy demonstrated benefit for patients with HR /HER2-, node-positive, high risk early #BreastCancer who received neoadjuvant chemotherapy before trial enrolment. https://t.co/XqAmgwop4w #BCSM
#ESTROschool The IMRT faculty and ESTRO wants to thank the Institute of Oncology Ljubljana (AT), Primoz Strojan and the entire team for offering a highly substantial course, with insightful lectures and on-site demonstrations!
Our June issue is out!🎉
Featuring trials in multiple myeloma, AML, mycosis fungoides, and myelofibrosis, a Viewpoint making the case for the term "classical #hematology", a Review on cardioprotection for lymphoma patients, and more! #mmsm#leusm#lymsm https://t.co/EyrqUdHpyd